Global private equity and venture capital news and research

Posts Tagged ‘Actis’

1 April 2014

Actis sells down stake in listed Eqyptian bank CIB

news_egypt_protester_sml UK emerging markets private equity firm Actis has sold down its stake in Egyptian banking group Commercial International Bank (CIB) to 6.5 per cent.

3 February 2014

Actis invests in East African tyre company AutoXpress

Emerging market private equity firm Actis has acquired a 36 per cent equity interest in AutoXpress group, East Africa’s largest tyre wholesaler and retailer.

11 December 2013

Actis finally exits India’s Sterling Hospital 12 months after freezing sale processp

Sterling Hospital Global emerging markets investor Actis has finally agreed to exit its majority stake in Indian healthcare provider Sterling Hospital more than a year after putting the sale on ice.

9 December 2013

Actis holds $1.15bn final close for oversubscribed third energy fund

Global emerging markets investor Actis has confirmed it has held a $1.15bn final close for its heavily-oversubscribed third energy fund.

7 November 2013

Actis buys into Cameroon energy market through $220m power plants investment

Global private equity investor Actis is to buy into the Cameroonian energy market in an acquisition that sees it acquire three power production assets for $220m.

4 November 2013

Actis, Ethos sell Alexander Forbes unit Guardrisk for $157m

insurance contract form Private equity firms Actis and Ethos have agreed to sell Guardrisk, the specialist insurance unit of their financial services business Alexander Forbes, in a ZAR1.6bn ($157m) deal.

4 November 2013

Actis loses West African head Ngozi Edozienp

Emerging markets investment firm Actis has confirmed that Ngozi Edozien, a director and head of its West African office, has left the firm.

31 October 2013

IPOs in wind sector near $1bn in third quarterp

IPO activity in the wind sector is on the rise as the renewable energy industry matures and conditions in capital markets improve, a recent report showed.

23 October 2013

Mixed fortunes for Actis as it nears $2.8bn final closes for two funds

UK emerging markets investor Actis is nearing a final close for about $2.8bn of capital across two vehicles after scaling back fundraising ambitions for its latest global fund.

22 October 2013

Actis backs India’s Symbiotec Pharmalab with $48m

Private equity firm Actis has backed Indian pharmaceuticals business Symbiotec Pharmalab with a $48m investment.

Page 1 of 41234

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014